Nadler, Eric
Arondekar, Bhakti
Aguilar, Kathleen Marie http://orcid.org/0000-0002-2467-8663
Zhou, Jie
Chang, Jane
Zhang, Xinke
Pawar, Vivek
Funding for this research was provided by:
Pfizer
Article History
Received: 29 May 2020
Accepted: 18 August 2020
First Online: 2 December 2020
Compliance with ethical standards
:
: Dr. Nadler reports that he was employed by Texas Oncology and provided research support to Pfizer and Merck KGaA, Darmstadt, Germany, during the course of the study. Dr. Arondekar and Ms. Chang report that they were employed by Pfizer during the course of the study. Ms. Aguilar and Dr. Zhou report that they were employed by McKesson Life Sciences and provided research support to Pfizer and Merck KGaA, Darmstadt, Germany during the course of the study. Dr. Zhang and Dr. Pawar report that they were employed by EMD Serono Research & Development Institute, Inc., a business of Merck KGaA, Darmstadt, Germany, during the course of the study.
: The study was reviewed and granted an exception and waiver of consent by the US Oncology, Inc, Institutional Review Board. This study was conducted in accordance with the Declaration of Helsinki.
: All authors have reviewed the final version of the manuscript and are in agreement its content and submission.